TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

Similar documents
Approved for public release; distribution unlimited

Award Number: W81XWH

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Fort Detrick, Maryland

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

Award Number: W81XWH

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

Approved for public release; distribution unlimited

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

AD (Leave blank) TITLE: Brief cognitive behavioral therapy for military populations

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Detection of Prostate Cancer Progression by Serum DNA Integrity

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

TITLE: Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/OND Male Veterans

TITLE: Mission Connect Mild TBI Translational Research Consortium. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Proteomic Mapping of the Immune Response to Gluten in Children with Autism

TITLE: Effect of Reminder Telephone Calls on Mammography Compliance in High Risk

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

Award Number: W81XWH TITLE: Regenerative Stem Cell Therapy for Breast Cancer Bone Metastasis

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

TITLE: A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-1 53 in Localized, High-Risk, Prostate Cancer

TITLE: Estrogen-DNA Adducts as Novel Biomarkers for Ovarian Cancer Risk and for Use in Prevention

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Decreasing Skin Graft Contraction through Topical Wound Bed Preparation with Anti-Inflammatory Agents. Tacoma, WA 98402

TITLE: Improving Work Outcomes for Veterans with Traumatic Brain Injury. San Diego, CA 92161

Promote Adjustment during Reintegration following Deployment

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine, New York, NY 10029

TITLE: The Role Of Alternative Splicing In Breast Cancer Progression

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

TITLE: Investigation of the Akt/PKB Kinase in the Development of Hormone-Independent Prostate Cancer

TITLE: Prostate Expression Databases: Gene Expression Resources for Comparative Studies of Prostate Carcinogenesis

Expression and Promoter Methylation of P16INK4A During Estrogen-Induced Mammary Carcinogenesis in the ACI Rat. Omaha, NE

TITLE: Exploring Early Detection Methods: Using the Intraductal Approach to Predict Breast Cancer

TITLE: Developing a Training Program in Breast Cancer Research to Decrease the Disparity of Morbidity and Mortality in Underserved/Minority Women

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

TITLE: Psychosocial Stress and Ovarian Cancer Risk: Metabolomics and Perceived Stress

Award Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.

RECIPIENT: Lankenau Institute for Medical Research, Wynnewood, PA 19096

TITLE: Gulf War Illness Evaluation of an innovative detoxification program

TITLE: Breast Density Assessment by Dual Energy X-ray Absorptiometry in Women and Girls. Rachel Novotny, Ph.D. Honolulu, HI 96822

CONTRACTING ORGANIZATION: Vanderbilt University Medical Center Nashville, TN

TITLE: Functional Genetics for Predisposition to Development of Type 2 Diabetes in Obese Individuals. PRINCIPAL INVESTIGATOR: Assia Shisheva

TITLE: Using Propranolol to Block Memory Reconsolidation in Female Veterans with PTSD

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Transcription:

Award Number: W81XWH-10-1-0959 TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation PRINCIPAL INVESTIGATOR: Andrea Behrman CONTRACTING ORGANIZATION: University of Florida Gainesville, FL 32611 REPORT DATE: October 2012 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Approved for public release; distribution unlimited The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE (DD-MM-YYYY) 1 October 2012 4. TITLE AND SUBTITLE 2. REPORT TYPE Annual Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation 3. DATES COVERED (From - To) 9-30-2011-9-29-2012 5a. CONTRACT NUMBER W81XWH-10-1-0959 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Andrea L. Behrman, Ph.D., P.T. D. Michele Basso, Ed.D., PT Craig Velozo, PhD, OT 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) University of Florida Gainesville, FL 32611 8. PERFORMING ORGANIZATION REPORT NUMBER 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) U.S. Army Medical Research and Material Command Fort Detrick, Maryland, 21702-5012 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for public release; distribution unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT This multi-centered study (7 performance sites) assesses the responsiveness of the Neuromuscular Recovery Scale (NRS) for people with spinal cord injury. The NRS evaluates true recovery of pre-injury movement, rather than compensatory progress, during inpatient and outpatient rehabilitation for spinal cord injury. At the time of this report, approvals have been received and are current for the coordinating site, the University of Florida and for six clinical performance sites, the Ohio State University, Frazier Rehabilitation Institute, Kessler Rehabilitation Institute, TIRR at Memorial Hermann, Shepherd Center, Magee Rehabilitation Hospital. One site has IRB proposal under review. Enrollment and data collection continue at all approved sites with 72% of the outpatient population completed and 19% of the in-patient population completed both initial and discharge NRS evaluations. Website construction is under development through streaming web services at Ohio State University (OSU) to provide an introduction to the NRS via video and an instructional guide. 15. SUBJECT TERMS Neuromuscular Recovery Scale (NRS), spinal cord injury, multicenter study 16. SECURITY CLASSIFICATION OF: U a. REPORT U b. ABSTRACT U c. THIS PAGE U 17. LIMITATION OF ABSTRACT UU 18. NUMBER OF PAGES 8 19a. NAME OF RESPONSIBLE PERSON USAMRMC 19b. TELEPHONE NUMBER (include area code) Standard Form 298 (Rev. 8-98) Prescribed by ANSI Std. Z39.18

Table of Contents Page Introduction..... 5 BODY.. 6 Key Research Accomplishments... 8 Reportable Outcomes 9 Conclusion 9 References. 9 Appendices 9

Introduction The purpose of this study is to assess the responsiveness of the phase system (Neuromuscular Recovery Scale, NRS) in measuring recovery from SCI over time and across therapy settings. This scale uniquely detects return of normal function over time after SCI. Compensation for weakened or paralyzed muscles by stronger muscles, substitutions, or devices do not contribute to the score. Preliminary data indicate the current utility of the NRS to distinctly classify people with SCI based on performance of normal, pre-morbid movement function. Our intent is that the NRS will serve as a clinically-relevant SCI outcome measure for use in rehabilitation clinics, cohort studies, and randomized clinical trials. Hypothesis We hypothesize that individuals post-sci undergoing physical rehabilitation will demonstrate significant change in Neuromuscular Recovery Scale scores from initial to discharge evaluations during the period of a) in-patient rehabilitation and usual care and b) outpatient rehabilitation (chronic SCI) receiving an intense, activity-based therapy. Specific Aims Aim 1: Assess the responsiveness of the Neuromuscular Recovery Scale for evaluating recovery from SCI over the period of 1) in-patient rehabilitation (sub-acute SCI) receiving usual care and 2) outpatient rehabilitation (chronic SCI) while receiving an intense, activity-based therapy. A) Ninety-four patients, AIS A, B, C & D undergoing usual care rehabilitation in an inpatient setting during the sub-acute period post-sci will be enrolled for completion of initial and discharge Phase System evaluations. We anticipate attrition will result in a study population of 72 subjects with initial and discharge evaluations. B) Seventy-two NeuroRecovery Network (NRN) patients, chronic AIS A-D undergoing the standardized locomotor training program in an out-patient rehabilitation program will undergo initial and discharge evaluations. Only persons included in the NRN database having completed both initial and discharge evaluations will be included in our dataset. Relevance The results of this study will establish the ability of the NRS to detect rehabilitationinduced changes in recovery of function after acute or chronic SCI. By being able to classify initial functional deficits with the NRS, we will be able to better tailor interventions for each individual with SCI. By including VA and military personnel in the study, incorporation of the NRS in the care and treatment of soldiers or veterans with SCI will be immediate. Furthermore, web documents will support training of other military rehabilitation centers. 5

Body Year 1: As outlined in our SOW, we dedicated considerable time attaining human subject approval, setting up procedures and attaining electronic data transfer approval for the Tampa VA, training the James A Haley VA Medical Hospital (Tampa VA) physical therapists and enrolling subjects. As we are leveraging the standard clinical practice of the NeuroRecovery Network (NRN) in routinely evaluating out-patients with the NRS at initial evaluation and discharge, we additionally incorporated three upper extremity items consistent with the NRN. These items were added to the NRS in May, 2011 and should assist in better gauging responsiveness as now the legs, trunk, and arms are all encompassed in the assessment. The approved IRB includes all of these items. Task 1. Prepare and standardize all sites (NRN and Tampa VA) for data collection (Months 0-10) 1a. Planning meetings held among partnering investigators, statistician, and Systemax Corp. COMPLETED, YEAR 1 1b. Planning meeting held for NRN sites and Tampa VA with a) site PI and b) site Supervisors; ongoing monthly meetings scheduled COMPLETED,YEAR 1 1c. Prepare and submit IRB materials to each institution. Revise, as requested by IRB for approval. COMPLETED, YEAR 2 for the six NRN sites. Annual renewals completed for all six and the coordinating center at UF. The Tampa VA site s IRB is currently under review. Milestone #1 Human Use Approvals Tampa VA IRB documents are under review. Since our last report, one of the 7 NRN centers left the network without completing IRB or enrolling any subjects. Six NRN centers remain. YEAR 2 1d. Tampa VA study staff visits NRN-OSU clinical site for Phase System/NRS training. On-site competency skills checklist completed and passed. COMPLETED, YEAR 1 1e. After practice with 3-5 patients, Tampa VA completes and passes competency skills checklist for conducting NRS at Tampa VA site via submission of Phase System/NRS evaluation recording. COMPLETED, YEAR 2, refresher competency proposed during NCE 1f. NRN sites and Tampa VA site establishes procedures for patient/subject referral and data collection with in-patient rehabilitation SCI program COMPLETED, YEAR 2. Milestone #2 All sites readied for data collection with Phase System instrument and inpatient SCI population 1g. Establish and modify database COMPLETED, YEAR 1 1h. Tampa VA site added to 7 NRN sites as a research site for data entry to database 6

DATABASE COMPLETED FOR VA SITE, YEAR 2. Current database system relies on use of SS#. This has hindered the use of the database for data entry and delivery from the Tampa VA site. Alternative routes have been discussed and put in place for VA data entry. 1i. Develop website for dissemination of instrument at introductory level including online video demonstrations. (preparation for dissemination Year 2) UNDERWAY-video production and web site in development at OSU, YEAR 2 Milestone #3. Active database for all partnering institutions and clinical sites COMPLETED, YEAR 2 Task 2 Determine responsiveness of the Phase System (9-20 months) 2a. Identify subjects from NRN outpatient Locomotor Training programs UNDERWAY and On-GOING (YEAR 2) at approved IRB sites (6 NRN sites) 2b. Collect NRS evaluation data at initial and discharge UNDERWAY and ON-GOING (YEAR 2) at approved IRB sites (6 NRN sites) 2c. Recruit subjects from Tampa VA & inpatient rehabilitation clinics (at NRN clinical sites) UNDERWAY and ON-GOING (YEAR 2) at 6 NRN sites and PENDING HUMAN SUBJECTS APPROVAL (Tampa VA site) (YEAR 2) 2d. Collect Phase evaluation data at initial and discharge UNDERWAY and ON-GOING (YEAR 2) at 6 NRN sites and PENDING HUMAN SUBJECTS APPROVAL (Tampa VA site) (YEAR 2) 2e. Data extractions requested from database, quality checks conducted. On-GOING (YEAR 2) Milestone #4. Produce Interim Report: Recruitment and Enrollment COMPLETED INTERIM REPORT, YEAR 1 2f. Analyze phase data from 1) in-patient and 2) out-patient rehabilitation programs UNDERWAY (YEAR 2), 1) in-patient data, 19% of data collection completed, 2) out-patient data, 72% (n=52) of data collected and undergoing cleaning process for preliminary analysis, 28% yet to be collected (n=20, however n=39 currently enrolled and receiving treatment). We are awaiting their discharge for completion of data set. 2g. Write manuscripts UNDERWAY (YEAR 2), Manuscript in progress for Introduction and Methods, and Data Preparation: quality control checks and cleaning for analysis Milestone #5 Final Report, Publications (2) and abstracts submitted for national conferences. YEAR 2 2 nd Year Progress Report Completed. No cost extensions requested from PI and 2 Partnering PIs. No manuscripts submitted and no publications to date. Quad Chart completed and submitted. 7

Milestone #6 Dissemination plan completed. 3a. Finalize informative materials re: Phase instrument for distribution in publications and on-line. UNDERWAY, ON-GOING, (YEAR 2) 3b. Finalize web-based introductory program to Phase Instrument. UNDERWAY, ON- GOING, (YEAR 2) 3c. Distribute to VA Health Care System SCI facilities and NRN sites. Presented methods to NRN site at National Summit meeting of 6 sites, 2012. Research outcomes planned for presentation at National Summit, May, 2013 and presentation to all sites. (ON-GOING, YEAR 2) Work with Tampa VA re: distribution to VA SCI Centers. (No Cost Extension) 3d. Submit abstract for national SCI conferences and VA. ON-GOING, YEAR 2 Abstract submitted re: Neuromuscular Recovery Scale (NRS) for presentation at American Spinal Injury Association Meeting, May 2013 Abstract accepted for Combined Sections Meeting, APTA, Jan. 2013, only methods to be presented in context of introduction of NRS Invited lecture, Braintree Rehabilitation Conference, Nov. 2012, only methods to be presented in context of introduction of NRS as new outcome measure and potential utility Key Research Accomplishments, YEAR 2 Data Collection In-patient enrollment and data acquisition is currently at 19% (n=13) of the targeted population of n=72 subjects with both initial and discharge evaluations. As indicated in the Interim Year 1 Report, a longer period for IRB approval, one site leaving the NRN, and the TAMPA VA IRB finally under review, has meant that an extension of grant time is required to complete the data collection. Solution: Each site is expected to increase enrollment to 2 evaluations per month. At this rate and with the six approved sites participating, the sites should achieve the target goal before June, 2013. Out-patient enrollment and data collection is currently at 72% (n=52). 28% (n=20) have yet to be completed. However, 39 enrollees have completed an initial NRS and when 20/39 are discharged with a second, completed NRS evaluation, the outpatient enrollment will be completed. Solution: A No Cost Extension request has been submitted by the PI, Craig Velozo (University of Florida) and Partnering PIs each, Michele Basso (Ohio State University), and Andrea Behrman (University of Louisville) for continued enrollment and grant funding through a 3 rd year (2012-2013) to complete data collection, subsequent analysis, manuscript preparation and submission, and dissemination. Data Analysis Quality control checking and data cleaning has begun with the out-patient dataset (n=52). As the additional n=20 is added, this dataset will be checked. Data cleaning of in-patient data will follow with the 19% collected and then every subsequent 20% through completion. Data analysis will begin and manuscript results section written. 8

Abstracts and Manuscripts Two abstracts have been submitted: o APTA Combined Sections Meeting, 2013, accepted, responsiveness study methods only to be reported and the NRS instrument introduced o American Spinal Injury Association, May, 2013, symposium proposal submitted and under review o If military associated conference occurs in the next year, preference to submit and attend for distribution to associated military and VA sites. Invited presentations: o Braintree Rehabilitation Conference, Nov. 2012, Boston, methods only to be reported and the NRS instrument introduced o Brazilian NeuroPhysical Therapy Conference, Nov. 2012, methods only to be reported and the NRS instrument introduced o 4 th International Congress of Neuronal Plasticity and Brain Restoration, Merida, Mexico, Oct 2012, methods only to be reported and NRS instrument introduced. Responsiveness Manuscripts o In-patient Data cleaning underway, Introduction and Methods in preparation. o Out-patient Data cleaning underway, Introduction and Methods in preparation. Reportable Outcomes None at this time Conclusion We have completed IRB approval and renewals for Year 2 and 3, with the exception of the Tampa VA. We have advanced subject enrollment in Year 2, however, we will require a no cost extension to complete the in-patient and out-patient enrollment. We have initiated preparation for the web site for dissemination, submitted 2 abstracts (one focuses on methods, one will include results) to national SCI and Physical Therapy conferences, and are including an introduction to the instrument and methods at three invited presentations (one national, two international). We will focus on reportable outcomes in Year 3, should no-cost extension be extended, including activation of the web site, submission of 2 manuscripts and dissemination of findings at national meetings. References None Appendices None 9